Cargando…
Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE)
BACKGROUND: Neuron-specific enolase (NSE) and S-100b have been used to assess neurological damage following out-of-hospital cardiac arrest (OHCA). Cut-offs were derived from small normothermic cohorts. Whether similar cut-offs apply to patients treated with hypothermia remained undetermined. METHODS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790428/ https://www.ncbi.nlm.nih.gov/pubmed/33411836 http://dx.doi.org/10.1371/journal.pone.0245210 |
_version_ | 1783633423842148352 |
---|---|
author | Akin, Muharrem Garcheva, Vera Sieweke, Jan-Thorben Adel, John Flierl, Ulrike Bauersachs, Johann Schäfer, Andreas |
author_facet | Akin, Muharrem Garcheva, Vera Sieweke, Jan-Thorben Adel, John Flierl, Ulrike Bauersachs, Johann Schäfer, Andreas |
author_sort | Akin, Muharrem |
collection | PubMed |
description | BACKGROUND: Neuron-specific enolase (NSE) and S-100b have been used to assess neurological damage following out-of-hospital cardiac arrest (OHCA). Cut-offs were derived from small normothermic cohorts. Whether similar cut-offs apply to patients treated with hypothermia remained undetermined. METHODS: We investigated 251 patients with OHCA treated with hypothermia but without routine prognostication. Neuromarkers were determined at day 3, neurological outcome was assessed after hospital discharge by cerebral performance category (CPC). RESULTS: Good neurological outcome (CPC≤2) was achieved in 41%. Elevated neuromarkers, older age and absence of ST-segment elevation after ROSC were associated with increased mortality. Poor neurological outcome in survivors was additionally associated with history of cerebrovascular events, sepsis and higher admission lactate. Mean NSE was 33μg/l [16–94] vs. 119μg/l [25–406]; p<0.001, for survivors vs. non-survivors, and 21μg/l [16–29] vs. 40μg/l [23–98], p<0.001 for good vs. poor neurological outcome. S-100b was 0.127μg/l [0.063–0.360] vs. 0.772μg/l [0.121–2.710], p<0.001 and 0.086μg/l [0.061–0.122] vs. 0.138μg/l [0.090–0.271], p = 0.009, respectively. For mortality, thresholds of 36μg/l for NSE and 0.128μg/l for S-100b could be determined; for poor neurological outcome 33μg/l (NSE) and 0.123μg/l (S-100b), respectively. Positive predictive value for NSE was 81% (74–88) and 79% (71–85) for S-100b. CONCLUSIONS: Thresholds for NSE and S-100b predicting mortality and poor neurological outcome are similar in OHCA patients receiving therapeutic hypothermia as in those reported before the era of hypothermia. However, both biomarkers do not have enough specificity to predict mortality or poor neurological outcome on their own and should only be additively used in clinical decision making. |
format | Online Article Text |
id | pubmed-7790428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77904282021-01-27 Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) Akin, Muharrem Garcheva, Vera Sieweke, Jan-Thorben Adel, John Flierl, Ulrike Bauersachs, Johann Schäfer, Andreas PLoS One Research Article BACKGROUND: Neuron-specific enolase (NSE) and S-100b have been used to assess neurological damage following out-of-hospital cardiac arrest (OHCA). Cut-offs were derived from small normothermic cohorts. Whether similar cut-offs apply to patients treated with hypothermia remained undetermined. METHODS: We investigated 251 patients with OHCA treated with hypothermia but without routine prognostication. Neuromarkers were determined at day 3, neurological outcome was assessed after hospital discharge by cerebral performance category (CPC). RESULTS: Good neurological outcome (CPC≤2) was achieved in 41%. Elevated neuromarkers, older age and absence of ST-segment elevation after ROSC were associated with increased mortality. Poor neurological outcome in survivors was additionally associated with history of cerebrovascular events, sepsis and higher admission lactate. Mean NSE was 33μg/l [16–94] vs. 119μg/l [25–406]; p<0.001, for survivors vs. non-survivors, and 21μg/l [16–29] vs. 40μg/l [23–98], p<0.001 for good vs. poor neurological outcome. S-100b was 0.127μg/l [0.063–0.360] vs. 0.772μg/l [0.121–2.710], p<0.001 and 0.086μg/l [0.061–0.122] vs. 0.138μg/l [0.090–0.271], p = 0.009, respectively. For mortality, thresholds of 36μg/l for NSE and 0.128μg/l for S-100b could be determined; for poor neurological outcome 33μg/l (NSE) and 0.123μg/l (S-100b), respectively. Positive predictive value for NSE was 81% (74–88) and 79% (71–85) for S-100b. CONCLUSIONS: Thresholds for NSE and S-100b predicting mortality and poor neurological outcome are similar in OHCA patients receiving therapeutic hypothermia as in those reported before the era of hypothermia. However, both biomarkers do not have enough specificity to predict mortality or poor neurological outcome on their own and should only be additively used in clinical decision making. Public Library of Science 2021-01-07 /pmc/articles/PMC7790428/ /pubmed/33411836 http://dx.doi.org/10.1371/journal.pone.0245210 Text en © 2021 Akin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Akin, Muharrem Garcheva, Vera Sieweke, Jan-Thorben Adel, John Flierl, Ulrike Bauersachs, Johann Schäfer, Andreas Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title | Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title_full | Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title_fullStr | Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title_full_unstemmed | Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title_short | Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) |
title_sort | neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the hannover cooling registry (hacore) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790428/ https://www.ncbi.nlm.nih.gov/pubmed/33411836 http://dx.doi.org/10.1371/journal.pone.0245210 |
work_keys_str_mv | AT akinmuharrem neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT garchevavera neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT siewekejanthorben neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT adeljohn neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT flierlulrike neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT bauersachsjohann neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore AT schaferandreas neuromarkersandneurologicaloutcomeinoutofhospitalcardiacarrestpatientstreatedwiththerapeutichypothermiaexperiencefromthehannovercoolingregistryhacore |